Nos complace anunciarles que hemos actualizado con éxito el RepHip a la versión 9.3 de Dspace. El repositorio ya está disponible para consultas, pero todavía no está disponible para subir nuevo material. En caso de experimentar algún problema, por favor contactarse a rephip@unr.edu.ar..

Clinical response in patients with ovarian cancer treated with metronomic chemotherapy

Miniatura

Archivos

Perroud et al 2017.pdf (517,38 KB)

Fecha

2017-02-28

Authors




Título de la revista

ISSN de la revista

Título del volumen

Editor

Cancer Intelligence

Resumen

Descripción

Ovarian cancer (OC) is the leading cause of death from gynaecological cancer. It is extremely hard to diagnose in the early stages and around 70% of patients present with advanced disease. Metronomic chemotherapy (MCT) is described as the chronic administration of, generally low, equally spaced, doses of chemotherapeutic drugs with therapeutic efficacy and low toxicity. This is an effective and low-cost way to treat several types of tumours, including ovarian cancer. Here, we present six cases of advanced ovarian cancer treated with MCT with low doses of cyclophosphamide, which showed clinical response and stable disease.

Palabras clave

ovarian cancer, metronomic chemotherapy, cyclophosphamide

Citación

URI

http://hdl.handle.net/2133/11512

Colecciones

CIUNR - Ciencias Naturales - Artículos de Revista
FCM - SCTeI - Artículo de Revista de Investigación

Aprobación

Revisión

Complementado por

Referenciado por

Licencia Creative Commons

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Excepto donde se indique lo contrario, la licencia de este ítem se describe como This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.